Panel Discussion:Driving Consensus on Analytical Validation Requirements to Expedite Liquid Biopsy Integration in Oncology
Time: 12:00 pm
day: Conference Day 2
Details:
- What regulatory and industry collaborations are needed to drive consensus on analytical validation requirements for liquid biopsy in oncology?
- How can we ensure that liquid biopsy assays are validated for their intended use in clinical trials to avoid discrepancies in biomarker interpretation?
- Given the lack of standardization in LBx, what steps should be taken to ensure consistency across platforms?
